Clinical Trials Directory

Trials / Unknown

UnknownNCT03252548

Pediatric Primary Immunodeficiency Disease (PID) in China

Clinical Characteristics and Prognosis of Primary Immunodeficiency Disease (PID) in Chinese Children

Status
Unknown
Phase
Study type
Observational
Enrollment
400 (estimated)
Sponsor
Beijing Children's Hospital · Academic / Other
Sex
All
Age
1 Day – 18 Years
Healthy volunteers
Not accepted

Summary

This study is a prospective cohort study of children diagnosed with primary immunodeficiency disease (PID). The aim is to investigate the clinical characteristics and prognosis of PID in Chinese children.

Detailed description

Primary immunodeficiency disease (PID) is a group of rare and fatal disease. However, the research about clinical characteristics, treatment, management and prognosis of Chinese children with PID is still not perfect and there is no basic and large database. Therefore, this study is conducted, in order to set up a complete database and long term follow up of Chinese children with PID, and establish foundations for basic research and precise medicine. This study is divided into two parts. In part one, pediatric patients with PID in the past 10 years will be collected retrospectively by review medical records from these centers, and investigate the clinical features and prognosis. In part two, all new cases with suspected PID will be collected. Clinical symptoms, physical examination, blood tests, and humoral and cellular immune functions will be detected. Gene tests would be done when necessary to confirm the diagnosis. Then follow up at 6-moth, 1-year, 2-year, 3-year, 4-year and 5-year respectively. The trial will be completed in 60 months.

Conditions

Timeline

Start date
2018-01-01
Primary completion
2022-08-01
Completion
2022-08-01
First posted
2017-08-17
Last updated
2018-01-03

Source: ClinicalTrials.gov record NCT03252548. Inclusion in this directory is not an endorsement.